Showing results (31-40 of 1,374) with videos related to
Sort By:
Pageof 138
Genetics and Molecular Research : GMR|December 15, 2015
Development of microsatellite loci for Taxus wallichiana var. wallichiana (Taxaceae) and cross-amplification in TaxaceaeB B Cheng, Q W Sun, Y Q ZhengJournal of Ocular Pharmacology|January 1, 1990
Adjustment of blood sugar levels with insulin and glucagon eyedrops in normal and diabetic rabbitsG C Chiou, Z F Shen, Y Q ZhengLin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery|October 5, 2018
[Outcomes of same-day bilateral endoscopic tympanoplasty]Y R Dai, H D Yang, Y Q ZhengZhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|December 30, 2020
[Introduction to COSMOS-E: Guidance on conducting systematic reviews and Meta-analyses on etiology of observational studies]W W Wang, Z R Yang, Q X Zhou, et al.Journal of Ocular Pharmacology|January 1, 1991
Systemic absorption of oxytocin and vasopressin through eyes in rabbitsG C Chiou, Z F Shen, Y Q ZhengZhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|January 3, 2018
[Risk and related factors on metabolic syndrome among people who had received screening on physical check-up programs, in China]H Y Zhao, J Yang, F Sun, et al.Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|April 21, 2021
[Accuracy of Xpert® MTB/RIF for the detection of tuberculosis and rifampicin-resistance tuberculosis in China: A systematic review and meta-analysis]J N Feng, L Gao, Y X Sun, et al.Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|February 24, 2017
[Application of disease-risk score in pharmacoepidemiologic studies]H Y Zhao, S Y ZhanZhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|July 26, 2016
[Active surveillance of adverse drug reaction in the era of big data: challenge and opportunity for control selection]S F Wang, S Y ZhanZhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|March 2, 2018
[The PRECIS-2 tool: designing trials that are fit for purpose]G P Hu, S Y ZhanPageof 138